NCT03978520COVID-19upadacitinibPBOUPASLESLEek
…bjective of this post hoc analysis of the phase 2 SLEek study ( NCT03978520) was to evaluate the achievement of LLDAS and DORIS with upadac…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT03978520 ×
NCT03978520
This institution is selected. Its supporting articles are shown below.